GlassScriptPhysician profile
Barton H Ueki
NPI 1043219355
$4,070.85
in general payments reported to CMS, 2019-2025
10 companies · $232 in 2025
The $232 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $777 · 2021: $1,040 · 2022: $708 · 2023: $535 · 2024: $422 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,189.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,680.87 | 2019-2025 | Xifaxan, Plenvu, Trulance |
| Gilead Sciences, INC. | $1,395.85 | 2019-2025 | |
| Abbvie INC. | $628.00 | 2020-2025 | Mavyret, Skyrizi |
| Intercept Pharmaceuticals, INC. | $132.55 | 2020-2024 | Ocaliva |
| Madrigal Pharmaceuticals | $114.58 | 2024-2025 | Rezdiffra, Resmetirom |
| Redhill Biopharma INC. | $40.28 | 2020-2021 | |
| Aimmune Therapeutics, INC. | $20.71 | 2023 | |
| Braintree Laboratories, INC. | $20.36 | 2020 | |
| Merck Sharp & Dohme LLC | $19.88 | 2019 | |
| Mallinckrodt Hospital Products INC. | $17.77 | 2023 | Terlivaz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barton Ueki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.